Clinical trial

Aripiprazole Effects on Alcohol Reactivity and Consumption

NCT00183235 · Medical University of South Carolina, Other · Completed

Key facts

NCT number NCT00183235
Title Aripiprazole Effects on Alcohol Reactivity and Consumption
Official title Effectiveness of Aripiprazole to Reduce Craving for Alcohol and Drinking Under Natural Observation, During Cue Induced Brain Imaging, and During a Motivated Free Choice Drinking Procedure Compared to Placebo
Lead sponsor Medical University of South Carolina, Other
Collaborators National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Alcohol Dependence
Intervention type Drug
Interventions aripiprazole (up to 15 mg/day) for 8 days
Enrollment 30
Start date Jun 1, 2005
Completion Feb 1, 2006
First posted Sep 16, 2005
Last update posted May 5, 2010
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies